Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function

Molecular Pharmaceutics

Volumn 4, Issue 2, 2007, Pages 199-207

  Jia, Xiangxu ^a   Cheng, Kun ^a   Mahato, Ram I ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE   (United States)

Author keywords

Bicistronic plasmid; hIL 1Ra; Human islet; hVEGF; Insulin release; Real time RT PCR

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOFECTAMINE; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LIPOSOMAL GENE DELIVERY SYSTEM; MOLECULAR CLONING; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CASPASES; CELL DEATH; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; ISLETS OF LANGERHANS; NITRIC OXIDE; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34247354627     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060091s     Document Type: Article

References (21)

1. Garcia-Ocana, A.; Takane, K. K.; Reddy, V. T.; Lopez-Talavera, J. C.; Vasavada, R. C.; Stewart, A. F. J. Biol. Chem. 2003, 278, 343-51.
2. Ryan, E. A.; et al. Diabetes 2002, 51, 2148-57.
3. Embury, J.; et al. Diabetes 2001, 50, 1706-13.
4. Contreras, J. L.; et al. Transplantation 2001, 71, 1015-23.
5. Giannoukakis, N.; Rudert, W. A.; Ghivizzani, S. C.; Gambotto, A.; Ricordi, C.; Trucco, M.; Robbins, P. D. Diabetes 1999, 48, 1730-6.
6. Gorden, D. L.; Mandriota, S. J.; Montesano, R.; Orci, L.; Pepper, M. S. Transplantation 1997, 63, 436-43.
7. Menger, M. D.; Vajkoczy, P.; Beger, C.; Messmer, K. J. Clin. Invest. 1994, 93, 2280-5.
8. Lukinius, A.; Jansson, L.; Korsgren, O. Am. J. Pathol. 1995, 146, 429-35.
9. Narang, A. S.; Cheng, K.; Henry, J.; Zhang, C.; Sabek, O.; Fraga, D.; Kotb, M.; Gaber, A. O.; Mahato, R. I. Pharm. Res. 2004, 21, 15-25.
10. Narang, A. S.; Mahato, R. I. Pharmacol. Rev. 2006, 58, 194-243.
11. Narang, A. S.; Sabek, O.; Gaber, A. O.; Mahato, R. I. Pharm. Res. 2006, 23, 1970-1982.
12. Corbett, J. A.; Sweetland, M. A.; Wang, J. L.; Lancaster, J. R., Jr.; McDaniel, M. L. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1731-5.
13. Arnush, M.; Heitmeier, M. R.; Scarim, A. L.; Marino, M. H.; Manning, P. T.; Corbett, J. A. J. Clin. Invest. 1998, 102, 516-26.
14. Eizirik, D. L.; et al. J. Clin. Invest. 1994 93, 1968-74.
15. Zhang, N.; et al. Diabetes 2004, 53, 963-70.
16. Bertera, S.; Alexander, A. M.; Crawford, M. L., Papworth, G.; Watkins, S. C.; Robbins, P. D.; Trucco, M. Exp. Diabesity Res. 2004, 5, 201-10.
17. Welsh, N.; Bendtzen, K.; Welsh, M. J. Clin. Invest. 1995, 95, 1717-22.
18. Teschendorf, C.; Warrington, K. H., Jr.; Siemann, D. W.; Muzyczka, N. Anticancer Res. 2002, 22, 3325-30.
19. Elliott, M. D.; Kapoor, A.; Parker, M. A.; Kaufman, D. B.; Bonow, R. O.; Gheorghiade, M. Circulation 2001, 104, 563-9.
20. Chung, S.; Andersson, T.; Sonntag, K. C.; Bjorklund, L.; Isacson, O.; Kim, K. S. Stem Cells 2002, 20, 139-45.
21. Ristimaki, A.; Narko, K.; Enholm, B.; Joukov, V.; Alitalo, K. J. Biol. Chem. 1998, 273, 8413-8.